Viewing Study NCT04366232


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-02-02 @ 6:45 PM
Study NCT ID: NCT04366232
Status: TERMINATED
Last Update Posted: 2020-12-16
First Post: 2020-04-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID View
None SARS-CoV-2 View
None Anakinra View
None Ruxolitinib View
None IL-1 inhibitors View
None JAK inhibitors View